维京治疗 VKTX
$26.84 +$1.05 (+4.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $26.80 -0.15%
开盘$25.81
昨收$25.79
当日区间$25.55 – $27.03
成交量2.67M
市值$3.42B
市盈率（TTM）–
股息率–
VKTX 相关新闻
匹配 Viking Therapeutics 或代码 VKTX 的头条新闻，按最新排序。
- B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85
- Viking Therapeutics | 8-K: Current report
- Viking Therapeutics | 424B5: Prospectus
- Viking Therapeutics | 424B5: Prospectus
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125
- Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)
- Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) 正面
- Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
- Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
- J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65 负面
- Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70
- Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
- Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114
暂无评论——快来第一个聊聊 VKTX。